About Accellix’s Next-Generation Flow Cytometry Technology

Accellix Executive Team

Greg Hamilton

Chief Executive Officer

Greg joined Accellix as it's Chief Executive Officer in September 2024. Prior to joining Accellix, Mr. Hamilton was CEO and Board member of io9 Inc., CEO and Executive Board member of Epigenomics AG, CEO and Director of AltheaDx Inc., Chief Operating Officer and Chief Financial Officer of Enigma Diagnostics Inc., Vice President of Operations and Finance at Third Wave Technologies Inc. and Vice President of Operations at Hologic Inc. He has executed multiple corporate transactions, raised significant financings, and been responsible for a series of FDA-cleared products over the course of his career. Mr. Hamilton received his MBA from the University of Chicago and his Bachelor of Science in Finance from Purdue University.

Rey Mali

Chief Operating Officer

Rey is the Chief Operating Officer at Accellix. She served as Chief Business Officer and Vice President of Sales and Marketing from July 2019. She has served as a Product Development and Marketing leader for the prior 14 years in both hi-tech and biotech companies.

Rey has a graduate degree in Medical Research and an MBA from The University of California, Berkeley. She started her career in pharmaceutical sales at Merck Pharmaceuticals. She then joined a biotech startup that was acquired by Life Technologies (Thermo Fisher) as a Field Applications Scientist (FAS), increasing customer acquisition and retention, and later was promoted to a Global Product Manager role at Life Technologies, where she launched and managed products in the molecular biology space. She then transitioned to a Sr. Product Marketing Manager at Illumina, where she launched and managed products in the sequencing space, and later served as the Product Marketing Director at Twist Bioscience, leading the global marketing team towards commercial product launches and a successful IPO. Prior to joining Accellix, she worked at the Chan Zuckerberg Initiative (CZI), leading the Product Marketing efforts of free technological tools to advance medical research.

Reed Hickey

VP Product

Reed joined Accellix in September of 2019. He brings more than 25 years of diverse experience in the life science industry, and particularly the tools industry. Reed has extensive operational experience as well as commercial operations experience.

Early in his career, Reed gained 15 years of academic research experience in the molecular biology and developmental cardiology fields. He started at the University of California San Diego, as a research associate and later became a laboratory manager at Yale University.

Reed joined Invitrogen in 2005, where he supported the creation of a protein expression custom business. In 2007, he transitioned to the management side of the business and has held various roles culminating in leading the synthetic biology and sample preparation business units at Thermo Fisher. As part of his business leadership role, Reed managed nine global sites for the custom oligo business and has built of the GeneArt gene synthesis site in Pleasanton, California. In 2017 Reed took over leading product management for Twist Bioscience. During his time at Twist, Reed was pivotal in the scaling up of the business, leading to the IPO of the company in 2018.

Zion Botesazan

VP Hardware & Software

Zion joined Accellix in 2013. He has served in key roles since and is currently Vice President of Hardware and Software. He brings to the company more than 20 years of diverse experience in the medical device industry.

Michael Sherriff

Global VP Sales & Marketing

Michael joined Accellix in 2023 as the Director of North American Sales. He brings over 25 years of commercial experience, with the past 10 years leading high-performing sales teams. He has a Bachelor of Science degree in Medical Technology from the University of Vermont and an MBA in International Business from Schiller International University in Heidelberg, Germany. Early in his career, his experience included working as an ASCP certified Medical Technologist at Boston Children's Hospital, Massachusetts General Hospital, and Massachusetts Eye and Ear Infirmary as manager of the Clinical Laboratories.

Michael made the move into the biotech and pharmaceutical industry in 2002 when he joined DuPont Qualicon as the North American Field Application Scientist and eventually transitioned to his first sales role as North American Sales Manager. Early in his sales career, Michael focused on microbial identification and detection solutions across the pharmaceutical, nutraceutical, food safety and biotech markets, developing the personal care/hygiene sector as a new market.

His deep background in pharma analytics and bioproduction includes technical sales management roles at Applied Biosystems, Life Technologies, and Thermo Fisher Scientific. Prior to joining Accellix, as the Northeast District Manager, BioProduction at Thermo Fisher Scientific, Michael led a team responsible for selling custom and OTS products for the purification, production chemicals and services, cell culture, single use technologies and pharma analytics business units. Michael currently leads Accellix's sales and marketing strategy, driving expansion of the Accellix platform into new markets on a global scale.

Félix Montero-Julian

VP Scientific Affairs

Félix joined Accellix in 2025 from bioMérieux, where he most recently served as Scientific Senior Director of Pharma Quality Control. He holds a PhD and Master of Science in Immunology from Aix-Marseille II University in France, and a degree in Industrial Biochemistry Engineering from Universidad Autónoma Metropolitana in Mexico. His deep scientific knowledge and leadership experience across cytometry, regulatory science, and pharmaceutical QC make him uniquely qualified to shape scientific strategy and partnerships and help to scale the impact of the Accellix Platform.

Prior to Accellix, his previous roles include Cytometry R&D Director at bioMérieux and Director of the Cellular Analysis Department at Beckman Coulter, underscoring a distinguished track record spanning biopharmaceuticals, industrial microbiology, and clinical diagnostics. He brings more than 30 years of international experience in scientific affairs, analytical development, and regulatory science to support Accellix’s strategic vision and innovation roadmap. A respected thought leader in the development and regulatory acceptance of analytical methods for advanced therapeutics and biomanufacturing, he has authored more than 60 scientific publications.

Félix leads Accellix’s scientific engagement strategy, driving cross-functional collaboration across R&D, regulatory, and commercial teams, and helping advance the company’s mission to make rapid, automated cytometry accessible and reliable for blood collection centers and cell therapy manufacturers.

About Accellix

The Accellix Mission